Bayer is voluntarily recalling two lots of Kogenate FS antihemophilic factor 2000 IU vials in U.S. to the patient level, FDA said in a statement.
- Certain vials from these two lots that were labeled as Kogenate FS actually contain the FVIII hemophilia A treatment, Jivi antihemophilic factor PEGylated-aucl 3000 IU, it said
©2019 Bloomberg L.P. All rights reserved. Used with permission
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.